$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
How much does a box of Anshengsa cost after it is included in medical insurance in 2021?
2025-10-19 11:44:20
Check Details
Ansantsa can significantly improve the survival time of patients with ALK-positive lung cancer
2025-10-19 11:44:20
Check Details
Does ALK-positive lung cancer require chemotherapy after taking XALKORI?
2025-10-19 11:44:20
Check Details
New drug for lung cancer immunotherapy: nivolumab
2025-10-19 11:44:20
Check Details
How much does a box of the new generation ALK inhibitor Ansantsa cost? Where to buy it?
2025-10-19 11:44:20
Check Details
Nivolumab can significantly improve the survival of patients with advanced lung cancer
2025-10-19 11:44:20
Check Details
First-line treatment for ALK-positive lung cancer; Xakori
2025-10-19 11:44:20
Check Details
Safety and effectiveness of Xakori in the treatment of ALK-positive lung cancer
2025-10-19 11:44:20
Check Details
Safety and effectiveness of nivolumab in the treatment of advanced non-small cell lung cancer
2025-10-19 11:44:20
Check Details
Safety and efficacy of nivolumab monotherapy in the treatment of advanced or metastatic squamous NSCLC_ Kanghule
2025-10-19 11:44:20
Check Details
Contraindications and precautions for patients with lung cancer taking Anshengsa
2025-10-19 11:44:20
Check Details
Instructions and precautions for taking the lung cancer targeted drug Xakori
2025-10-19 11:44:20
Check Details
1
2
...
9929
9930
9931
9932
9933
9934
9935
...
10211
10212
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Tabrecta (Capmatinib): A Targeted Therapy for METex14-Mutated NSCLC
2
Pazopanib Shows Promise as Second-Line Therapy for Aggressive Skin Cancer
3
Opicapone Contraindications: Essential Restrictions for At-Risk Groups
4
Finerenone: An Innovative Treatment for Diabetic Kidney Disease
5
Managing Immunotherapy-Related Adverse Events of Tarlatamab-Imdelltra: A Guide to Dual-Specific T Cell Engager Safety
6
Almonertinib Safety Guide: Managing Adverse Reactions in NSCLC Treatment with a 3rd-Gen EGFR TKI
7
Pimitespib Storage Guidelines: Temperature, Humidity & Light Control for Home Use
8
Sirolimus (Rapamune) Comprehensive Clinical Guide
9
Lusutrombopag Efficacy, Dosage and Storage Instructions
10
Icotyde (Icotrokinra) Side Effects, Pharmacokinetics and Storage Instructions
11
Cemiplimab (Libtayo) Drug Information
12
Enfortumab Vedotin (Padcev): Nectin-4-Targeted ADC for Advanced Urothelial Carcinoma